P3.08-16 Prognostic Value of PDL-1 Expression and Correlation Between Primary Tissue and Brain Metastases in Oligometastatic NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1767
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.08-06 Long-Term Survival for Brain-Only Oligometastatic NSCLC Patients Treated With Ablative Therapy (AT): Prognostic Factors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

13P Expression of Notch 1 and Notch 3 Proteins in Imprints of NSCLC: Correlation With Prognostic Factors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

MA11.06 Prognostic Value of Complement System in NSCLC and Its Association With PD-1 and PD-L1 Expression

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Diagnostic and Prognostic Value of Serum miR-15a and miR-16-1 Expression Among Egyptian Patients With Prostate Cancer

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

P3.08-04 OMEGA, a Randomized Trial of Local Ablative Therapy vs. Conventional Treatment in Oligometastatic NSCLC – Trial in Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Twist and N-Cadherin Expression in NSCLC

PLoS ONE
Multidisciplinary
2013English

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients With Acute Myeloblastic Leukemia

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2017English

PC09.01 Debate 1: Early vs Delayed Treatment of Asymptomatic Brain Metastases in Wild-Type NSCLC - Early

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy